What is the treatment for yeast in urine, specifically Candida species infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Yeast in Urine (Candiduria)

Fluconazole 200 mg (3 mg/kg) daily for 2 weeks is the first-line treatment for symptomatic Candida urinary tract infections caused by fluconazole-susceptible species. 1, 2

Diagnostic Approach

  • Candiduria with symptoms (like urinary frequency) suggests true infection rather than colonization, requiring treatment 1
  • Asymptomatic candiduria generally does not require treatment unless the patient has specific risk factors 3, 4
  • Imaging (ultrasound or CT) may be helpful to rule out structural abnormalities or fungus ball formation in patients with candiduria 1

Treatment Algorithm Based on Clinical Presentation

For Symptomatic Candida Cystitis:

  • First-line therapy: Fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1, 3
  • Alternative loading dose regimen: 200 mg loading dose followed by 100 mg daily for at least 4 days 5
  • Treatment should continue until symptoms resolve and urine cultures no longer yield Candida species 2, 1

For Fluconazole-Resistant Species (C. glabrata, C. krusei):

  • Amphotericin B deoxycholate (AmB-d) 0.3-0.6 mg/kg daily for 1-7 days 1, 4
  • Oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1, 2
  • For fungus balls: Surgical debridement plus systemic antifungal therapy; consider local irrigation with AmB-d at 50 mg/L of sterile water if direct access to the collecting system is available 2, 6

For Candida Pyelonephritis:

  • Fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks for susceptible organisms 3, 2
  • Amphotericin B deoxycholate is recommended for resistant species 2, 4

Special Populations Requiring Treatment Even When Asymptomatic

  • Neutropenic patients 3, 4
  • Low birth weight infants 3, 2
  • Patients undergoing urologic procedures (treat with fluconazole several days before and after) 3, 1
  • Severely immunocompromised patients with fever and candiduria 3, 4
  • Patients with urinary tract obstruction 3

Important Clinical Considerations

  • Fluconazole is preferred due to excellent urinary concentration of active drug 3, 7
  • Echinocandins and other azoles (besides fluconazole) have minimal urinary excretion and are generally ineffective for Candida UTI 1, 7
  • Lipid formulations of amphotericin B do not achieve adequate urine concentrations and should not be used for treating Candida UTI 1, 2
  • Removing predisposing factors (indwelling catheters, antibiotics) will clear candiduria in almost 50% of asymptomatic patients 7

Common Pitfalls to Avoid

  • Treating asymptomatic candiduria in patients without risk factors for dissemination 1, 4
  • Using antifungal agents with poor urinary excretion (echinocandins, voriconazole) for lower urinary tract infections 1, 6
  • Overlooking the possibility of disseminated candidiasis in high-risk patients with candiduria 1, 3
  • Failing to remove or replace indwelling urinary catheters when possible 7, 6

References

Guideline

Treatment of Candiduria with Urinary Frequency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Budding Yeast on Urinalysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Research

Fluconazole dose recommendation in urinary tract infection.

The Annals of pharmacotherapy, 2001

Research

Candida urinary tract infections--treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.